Bluejay Diagnostics, Inc. (Nasdaq:BJDX)
Health Care/Life Sciences • Medical Equipment/Supplies
CIK 1704287
Company
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Address
360 Massachusetts Avenue
Suite 203
Acton, Massachusetts 01720
360 Massachusetts Avenue
Suite 203
Acton, Massachusetts 01720
Employees
10
10
Stock Info
Close
$4.0900
$4.0900
Day Range
3.7017 - 4.0900
3.7017 - 4.0900
52 Week Range
3.0300 - 386.7200
3.0300 - 386.7200
Average volume
362.6K
362.6K
Short Interest
15.13K (02/14/25)
15.13K (02/14/25)
% of Float Shorted
2.74%
2.74%
Market Cap
$2.26M
$2.26M
Revenue
N/A
N/A
Net Income
-$9.95M
-$9.95M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
President, CEO, CFO, CAO & Director Indranil Dey |
Chairman Douglas C. Wurth |
Independent Director Gary G. Gemignani |
Independent Director Donald R. Chase |
Independent Director Frederick Schwartz Zeidman |
SEC filings
Date | Form | Event |
---|---|---|
4 Dec, 2024 | 8-K | |
18 Nov, 2024 | 8-K | |
14 Nov, 2024 | SC 13G/A | |
14 Nov, 2024 | SC 13G | |
7 Nov, 2024 | 10-Q | |
24 Oct, 2024 | 8-K | |
16 Oct, 2024 | DEFA14A | |
16 Oct, 2024 | 8-K | |
10 Sep, 2024 | DEF 14A | |
30 Aug, 2024 | PRE 14A | |
28 Aug, 2024 | 8-K | |
21 Aug, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
16 Jul, 2024 | DEF 14A | |
5 Jul, 2024 | PRE 14A | |
3 Jul, 2024 | SC 13G | |
28 Jun, 2024 | 8-K | |
28 Jun, 2024 | 424B1 | |
26 Jun, 2024 | EFFECT | |
25 Jun, 2024 | CORRESP | |
25 Jun, 2024 | CORRESP | |
24 Jun, 2024 | S-1/A | |
24 Jun, 2024 | UPLOAD | |
20 Jun, 2024 | 8-K | |
17 Jun, 2024 | S-1 | |
31 May, 2024 | 8-K | |
16 May, 2024 | 8-K | |
15 May, 2024 | 10-Q | |
15 Apr, 2024 | DEF 14A | |
5 Apr, 2024 | PRE 14A | |
2 Apr, 2024 | 8-K | CEO Change |
28 Mar, 2024 | 10-K | |
4 Mar, 2024 | 8-K | |
14 Feb, 2024 | SC 13G | |
3 Jan, 2024 | SC 13G | |
2 Jan, 2024 | 8-K | |
29 Dec, 2023 | 424B4 | |
27 Dec, 2023 | S-1/A | |
27 Dec, 2023 | 8-K | |
27 Dec, 2023 | EFFECT | |
22 Dec, 2023 | CORRESP | |
22 Dec, 2023 | CORRESP | |
21 Dec, 2023 | S-1/A | |
14 Dec, 2023 | 4 | |
14 Dec, 2023 | 4 | |
30 Nov, 2023 | UPLOAD | |
21 Nov, 2023 | S-1 | |
9 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
26 Oct, 2023 | 8-K | |
16 Oct, 2023 | 8-K | |
11 Oct, 2023 | 3 | |
2 Oct, 2023 | 8-K | |
28 Aug, 2023 | 424B5 | |
28 Aug, 2023 | 8-K | |
16 Aug, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
10 Aug, 2023 | 8-K | |
21 Jul, 2023 | 8-K | |
20 Jun, 2023 | EFFECT | |
15 Jun, 2023 | UPLOAD | |
15 Jun, 2023 | CORRESP | |
5 Jun, 2023 | S-3 | |
19 May, 2023 | 8-K | |
18 May, 2023 | DEF 14A | |
11 May, 2023 | 10-Q | |
10 May, 2023 | 8-K | |
8 May, 2023 | PRE 14A | |
1 May, 2023 | 10-K/A | |
27 Apr, 2023 | 8-K | |
31 Mar, 2023 | 4/A | |
31 Mar, 2023 | 4/A | |
28 Mar, 2023 | 4 | |
24 Mar, 2023 | 4 | |
20 Mar, 2023 | 10-K | |
20 Mar, 2023 | 8-K | |
16 Mar, 2023 | 3 | |
16 Feb, 2023 | 4 | |
13 Feb, 2023 | 4 | |
13 Feb, 2023 | 4 | |
13 Feb, 2023 | 4 | |
13 Feb, 2023 | 4 | |
13 Feb, 2023 | 4 | |
13 Feb, 2023 | 4 | |
27 Jan, 2023 | 8-K | |
9 Nov, 2022 | 10-Q | |
8 Nov, 2022 | 8-K | |
28 Oct, 2022 | 8-K | |
7 Sep, 2022 | 4 | |
10 Aug, 2022 | 10-Q | |
26 Jul, 2022 | 8-K | |
15 Jun, 2022 | 8-K | |
13 May, 2022 | DEF 14A | |
9 May, 2022 | 10-Q | |
27 Apr, 2022 | 4 | |
20 Apr, 2022 | 8-K | |
19 Apr, 2022 | S-8 | |
1 Apr, 2022 | 8-K | |
28 Mar, 2022 | 8-K | |
28 Mar, 2022 | 3 | |
28 Mar, 2022 | 4 | |
23 Mar, 2022 | 4 | |
23 Mar, 2022 | 4 | |
23 Mar, 2022 | 4 | |
23 Mar, 2022 | 4 | |
23 Mar, 2022 | 4 | |
21 Mar, 2022 | 4 | |
21 Mar, 2022 | 4 | |
18 Mar, 2022 | 4 | |
17 Mar, 2022 | 4 | |
16 Mar, 2022 | 4 | |
10 Mar, 2022 | 8-K | |
10 Mar, 2022 | 10-K | |
28 Feb, 2022 | 4 | |
28 Feb, 2022 | 4 | |
31 Jan, 2022 | 8-K | |
13 Jan, 2022 | 4 | |
13 Jan, 2022 | 4 | |
13 Jan, 2022 | 4 | |
13 Jan, 2022 | 4 | |
4 Jan, 2022 | SC 13G/A | |
22 Dec, 2021 | SC 13D | |
22 Dec, 2021 | SC 13D | |
17 Dec, 2021 | 4 | |
16 Dec, 2021 | 10-Q | |
16 Dec, 2021 | 8-K | |
24 Nov, 2021 | 3 | |
17 Nov, 2021 | SC 13G | |
16 Nov, 2021 | 8-K | |
12 Nov, 2021 | 424B4 | IPO completed |
9 Nov, 2021 | EFFECT | |
9 Nov, 2021 | S-1MEF | |
9 Nov, 2021 | 3 | |
9 Nov, 2021 | 3 | |
9 Nov, 2021 | 3 | |
9 Nov, 2021 | 3 | |
9 Nov, 2021 | 3 | |
9 Nov, 2021 | 3 | |
5 Nov, 2021 | CORRESP | |
5 Nov, 2021 | 8-A12B | |
5 Nov, 2021 | CERT | |
5 Nov, 2021 | CORRESP | |
3 Nov, 2021 | S-1/A | |
27 Oct, 2021 | FWP | |
25 Oct, 2021 | S-1/A | |
25 Oct, 2021 | CORRESP | |
15 Oct, 2021 | UPLOAD | |
4 Oct, 2021 | S-1 | |
4 Oct, 2021 | CORRESP | |
24 Sep, 2021 | UPLOAD | |
8 Sep, 2021 | DRSLTR | |
8 Sep, 2021 | DRS/A | |
20 Aug, 2021 | UPLOAD | |
22 Jul, 2021 | DRS | |
29 Jun, 2021 | D |
Last update:2025-03-06 13:06:36.946299
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.